Phospholipid scramblase 1: a frontline defense against viral infections
Frontiers in Cellular and Infection Microbiology · 03.04.2025 · 15
DOI: 10.3389/fcimb.2025.1573373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 03.04.2025. Verfasst von Alina X Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Brown University, Providence, RI, United States. Hauptthemen laut MEDLINE: Phospholipid Transfer Proteins, Virus Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association, NIGMS NIH HHS.
Abstract (Originalsprache)
Phospholipid scramblase 1 (PLSCR1) is the most studied member of the phospholipid scramblase protein family. Its main function is to catalyze calcium (Ca 2+ )-dependent, ATP-independent, bidirectional and non-specific translocation of phospholipids between inner and outer leaflets of plasma membrane. Additionally, PLSCR1 is identified as an interferon-stimulated gene (ISG) with antiviral activities, and its expression can be highly induced by all types of interferons in various viral infections. Indeed, numerous studies have reported the direct antiviral activities of PLSCR1 through interrupting the replication processes of a variety of viruses, including entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), nuclear localization of influenza A virus (IAV), and transactivation of human immunodeficiency virus (HIV), Epstein-Barr virus (EBV), human T-cell leukemia virus type-1 (HTLV1), human cytomegalovirus (HCMV) and hepatitis B virus (HBV). In addition to these direct antiviral activities, PLSCR1 also regulates endogenous immune components to defend against viruses in both nonimmune and immune cells. Such activities include potentiation of ISG transcription, activation of JAK/STAT pathway, upregulation of type 3 interferon receptor (IFN-λR1) and recruitment of Toll-like receptor 9 (TLR9). This review aims to summarize the current understanding of PLSCR1’s multiple roles as a frontline defense against viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Brown University, Providence, RI, United States.
Förderung
- NHLBI NIH HHS
- American Heart Association-American Stroke Association
- NIGMS NIH HHS
Zitieren
APA
Yang, A. X., Norbrun, C., Sorkhdini, P., & Zhou, Y. (2025). Phospholipid scramblase 1: a frontline defense against viral infections. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1573373
Vancouver
Yang AX, Norbrun C, Sorkhdini P, Zhou Y. Phospholipid scramblase 1: a frontline defense against viral infections. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1573373
BibTeX
@article{Yang2025,
author = {Yang, Alina X and Norbrun, Carmelissa and Sorkhdini, Parand and Zhou, Yang},
title = {Phospholipid scramblase 1: a frontline defense against viral infections},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1573373}
}
EUVIMED